MRI Predictors of Survival in Patients with Glioblastomas
Abstract
Objective: To evaluate predictive value of MRI findings in overall survival of glioblastoma patients.
Methods: A retrospective study was performed in 11 consecutive adult glioblastoma patients who underwent primary surgery, radiation and chemotherapy. The Kaplan-Meier curve was used to estimate overall survival probabilities. Fisher’s exact test or Mann-Whitney U Test was used to explore the association between clinical and imaging factors and 2-year survival.
Results: The median survival for glioblastoma patients in this study was 963 days. Patients with tumor necrosis less than 50%, presence of pre-operative non-enhancing tumor (nCET), perilesional edema less than tumor volume, presence of cystic portion, absence of multifocality, extent of resection more than 50% involving noneloquent location, and the mass effect more than 5 mm had positive trends of longer survival (more than 2 years) implying better prognosis. However, no statistical significance was demonstrated.
Conclusion: MR imaging features were useful predictors for survival in glioblastoma patients.
Keywords: MRI, glioblastoma, survival, predictor
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.